Comparative effect of interval and continuous training programs on serum uric acid in management of hypertension: Arandomized controlled trial

Journal of Strength and Conditioning Research

Volumn 25, Issue 3, 2011, Pages 719-726

  Lamina, Sikiru ^a  

^a FEDERAL UNIVERSITY OF TECHNOLOGY   (Nigeria)

Author keywords

Blood pressure; Exercise; Hypertension; Uric acid

Indexed keywords

ANTIHYPERTENSIVE AGENT; METHYLDOPA; URIC ACID;

AGED; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE; EXERCISE TEST; HEART RATE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; NIGERIA; OXYGEN CONSUMPTION; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SEDENTARY LIFESTYLE;

AGED; ANTIHYPERTENSIVE AGENTS; EXERCISE; EXERCISE TEST; HEART RATE; HUMANS; HYPERTENSION; MALE; METHYLDOPA; MIDDLE AGED; NIGERIA; OXYGEN CONSUMPTION; SEDENTARY LIFESTYLE; URIC ACID;

EID: 79953886819     PISSN: 10648011     EISSN: None     Source Type: Journal    
DOI: 10.1519/JSC.0b013e3181d09edf     Document Type: Article

References (47)

1. Akinpelu, AO. Responses of the Africa hypertensive to exercise training: Preliminary observations. J Hum Hypertens 4:74-76, 1990. (Pubitemid 20118104)
2. American College of Sports Medicine. ASCM's Guidelines for Exercise Testing and Prescription. 5th ed. Baltimore: Williams and Wilkins, 1995.
3. American College of Sports Medicine. Position stand: Physical activity, physical fitness, and hypertension. Med Sci Sports Exerc 25: i-x, 1993.
4. Anker, SD, Doehner, W, Rauchhaus, M, Sharma, R, Francis, D, Knosalla, C, Davos, CH, Cicoira, M, Shamim, W, Kemp, M, Segal, R, Osterziel, KJ, Leyva, F, Hetzer, R, Ponikowski, P, and Coats, AJ. Uric acid and survival in chronic heart failure: Validation and application in metabolic, functional, and hemodynamic staging. Circulation 107:1991-1997, 2003. (Pubitemid 36506072)
5. Bachorik, PS. Collection of blood sample for lipoprotein analysis. Clin Chem 28:1375-1378, 1982. (Pubitemid 12125080)
6. Barbieri, M, Ferrucci, L, Corsi, AM, Macchi, C, Lauretani, F, Bonafe, M, Olivieri, F, Giovagnetti, S, Franceschi, C, and Paolisso, G. Is chronic inflammation a determinant of blood pressure in the elderly? Am J Hypertens 16:537-543, 2003. (Pubitemid 36829702)
7. Becker, BF. Towards the physiological function of uric acid. Free Rad Biol Med 14:615-631, 1993. (Pubitemid 23172569)
8. Benegas, JR. Epidemiologia de la hypertension arterial en Espana. Prevalencia, conocimneto Ycontrol. Hypertension 16:315-322, 1999.
9. Brand, FN, McGee, DL, Kannel, WB, Stokes, J, and Castelli, WP. Hyperuricemia as a risk factor of coronary heart disease: the Framingham study. Am J Epidemiol 121:11-18, 1985. (Pubitemid 15150683)
10. Breckenridge, A. Hypertension and hyperuricaemia. Lancet 1:15-18, 1966.
11. Brooks, GA, Fahey, TD, and White, TP. Exercise Physiology, Human Bioenergetics and Its Application. 2nd ed. Mountain View, CA: May Field Publishing, 1996.
12. Campion, EW, Glynin, RJ, and DeLabry, LO. Asymptomatic hyperuricemia. Risks and consequences in the normative aging study. Am J Med 82:421-428, 1987.
13. Duarte, JAR, Appel, HJ, Carvalho, F, Bastos, M L, and Soares, JMC. Endothelium-derive d oxidative stress may contribute to exerciseinduced muscle damage. Int J Sports Med 14:440-443, 1993. (Pubitemid 23346630)
14. Filipovsky, J, Simon, J, Chqragtek, J, Rosolova, H, Haman, P, and Petrikova, V. Changes of blood pressure and lipid profile during a physical training course in hypertensive subjects. Cardiology 78:31-38, 1991.
15. Glantzounis, GK, Tsimoyiannis, EC, Kappas, AM, and Galaris, DA. Uric acid and oxidative stress. Current Pharmaceutical Design 11:4145-4151, 2005. (Pubitemid 41672464)
16. Golding, LA, Meyers, CR, and Sinniny, WE. Way to Physical Fitness. The Complete Carnote to Fitness Testing and Instruction. 3rd ed. Champaign, IL: Human Kinetics, 1989.
17. Hellsten, Y, Frandsen, U, Orthenblad, N, Sjødin, B, and Richter, EA. Xanthine oxidase in human skeletal muscle following eccentric exercise: A role in inflammation. J Physiol 498:239-248, 1997. (Pubitemid 27056893)
18. International Society for the Advancement of Kinanthropometry (ISAK). International Standards for Anthropometric Assessment. Patche Fstroom, South Africa: ISAK, 2001.
19. Jean-Michel, M, Bernard, C, Roland, A, Peter, W, Eoino, B, Daniel, D, Michael, FO, Karl-Henz, R, Ramon, P, Edward, B, Gerhart, H, and Michael, ES. Twenty-four hour ambulatory blood pressure monitoring efficacy of peridopril/Indapamide first line combination in hypertensive patients. Am J Hypertens 17:245-251, 2004.
20. Katzung, BG. Basic and Clinical Pharmacology. 7th ed. New York: Lange Medical Books/Craw Hill, 1998.
21. Lamina, S, Okoye CG, and Dagogo TT. Therapeutic effect of an interval exercise training program in the management of erectile dysfunction in hypertensive patients. J Clin Hypertens (Greenwich) 11:1-5, 2009.
22. Langlois, M, DeBacquer, D, Duprez, D, Debuyzere, M, Delanghe, J, and Blaton, V. Serum uric acid in hypertensive patients with and without peripheral arterial disease. Atherosclerosis 168:163-168, 2003. (Pubitemid 36555824)
23. Laterza, MC, Demator, LD, Trombetta, IC, Braza, AM, Roveda, F, Alves, MJ, Negrao, CE, and Rondon, MU. Exercise training restores baroreflex sensitivity in never trained hypertensive patients. Hypertension 49:1298-1306, 2007. (Pubitemid 46809372)
24. Lehto, S, Niskanen, L, Ronnemaa, T, and Laakso, M. Serum uric acid is a strong predictor of stroke in patients with non-insulindependent diabetes mellitus. Stroke 29:635-639, 1998. (Pubitemid 28145791)
25. Levine, W, Dyer, AR, Shekelle, RB, Schoenberger, JA, and Stamler, J. Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol 42:257-267, 1989. (Pubitemid 19117031)
26. Leyva, F, Anker, S, Swan, JW, Godsland, IF, Wingrove, CS, Chua, TP, Stevenson, JC, and Coats, AJS. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J 18:858-865, 1997. (Pubitemid 27208159)
27. Liese, AD, Hense, HW, Lowel, H, Doring, A, Tietze, M, and Keil, U. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases. Epidemiology 10:391-397, 1999. (Pubitemid 29288237)
28. Mancia, G, Ferari, L, Gregorini, L, Leonett, L, Terzoli, L, Biachini, C, and Zanchetti, A. Effects of treatment with methyldopa on basal haemodynamic and on rural control. In: The Therapeutics of Hypertension. Robertson, JS, Pickering, GW, and Goldwell, ADS, (eds.). London: Royal Society of Medicine and Academic Press Inc, Ltd. 1980. pp. 70-78.
29. Musa, DI. Ibrahim, DM, and Toriola, AL. Cardiorespiratory fitness and risk factors of CHD in pre-adolescent Nigerian girls. J Hum Move Studies 42:455-455, 2002.
30. Nakahama, H, Fukuch, K, Yoshihana, F, Nakamura, S, Inenaga, T, Takiuch, S, and Kamide, K. Efficiency of screening for primary aldosteronism by adrenocortical scintigraphy without discontinuing antihypertensive medication. Am J Heart 16:725-728, 2003. (Pubitemid 37175986)
31. Pallant, J. SPSS Survival Manual: A Step by Step Guide to Data Analysis Using SPSS. Berkshire, UK: Open University Press, 2001.
32. Pescatello, LS, Franklin, BA, Fagard, R, Farquhar, WB, Kelley, GA, and Ray, CA. American College of Sports Medicine. American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc 36:533-553, 2004.
33. Piug, JG and Ruilop, LM. Uric acid and cardiovascular risk factor in arterial hypertension. J Hypertens 17:869-872, 1999.
34. Pollock, ML and Wilmore, JH. Exercise in Health and Disease: Evaluation and Prescription for Prevention and Rehabilitation. 2nd ed. Philadelphia: WB Saunders Company, 1990.
35. Proctor, P. Electron-transfer factors in psychosis and dyskinesia. Physiol Chem Phys 4:349-360, 2005.
36. Ross, WD and Marfell-Jones, MJ. Physiological testing of the high performance athletes. In: Kinanthropometry. MacDugall, JD, Wenger, A, and Green, HJ, (eds.). Champaign, IL: Human Kinetics, 1991. pp. 223-308.
37. Salako, LA. Treatment of Hypertension: Cardiovascular Disease in Africa. Ibadan: Ciba Geigy Ltd, 1976.
38. Sastre, J, Gascó, AME, Ferrero, JA, Furukawa, T, and Viña, J. Exhaustive physical exercise causes and oxidation of glutathione status in blood. Prevention by antioxidant administration. Am J Physiol 263: R992-R995, 1992.
39. Smith, PJ, Blumenthal, JA, Babyk, MA, Georgiades, A, Hinderlister, A, and Sherwood, A. Effects of exercise and weight loss on depressive symptoms among men and women with hypertensive. J Pschosome Res 63:463-469, 2007. (Pubitemid 350007661)
40. Somani, SM and Husain, K. Interaction of exercise training and chronic ethanol ingestion on antioxidant system of rat brain regions. J Appl Toxicol 17:329-336, 1997. (Pubitemid 27400072)
41. Stewart, KJ, Bacher, AC, Turner, KL, Fleg, JL, Hees, PS, Shapero, EP, Tayback, M, and Ouyang, P. Effects of exercise on blood pressure in older person. Arch Intern Med 165:756-762, 2005.
42. Townsend, RR, McFadden, TC, Ford, V, and Cadee, JA. A randomized double blind, placebo-controlled trial of casein protein hydrolysate (C12 peptide) in human essential hypertension. Am J Hypertens 17:1056-1058, 2004. (Pubitemid 39469330)
43. Tykarski, A. Evaluation of renal handling of uric acid in essential hypertension: Hyperuricemic related to decreased urate secretion. Nephron 59:364-368, 1991.
44. Ulrik, W, Asbjorn, LP, Morten, B, Qivird, R, PerMagnus, H, Erik, TA, Jan, H, Stig, S, Jun, LS, Vibeke, V, Anja, B, Godfrey, S, Sonia, N, Oyvind, E, and Terje, S. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients. Circulation 115:3086-3094, 2007.
45. Waeber, B, Nussberger, J, and Brunner, HR. The rennin angiotension system: role in experimental and human hypertension. In: Pathophysiology of Hypertension: Regulatory Mechanisms. Zanchetti, A and Tarazi, RC, (eds.). Amsterdam: Elsevier, 1986. pp. 489-519.
46. Walker, AJ, Bassett, DR, Duey, WJ, Howley, ET, Bond, V, Torok, DJ, and Mancuso, P. Cardiovascular and plasma catecholamine responses to exercise in blacks and whites. Hypertension 20:542-548, 1992.
47. Ward, HJ. Uric acid as an independent risk factor in the treatment of hypertension. Lancet 352:670-671, 1998. (Pubitemid 28398697)